echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > BP: Chinese medicine can assist in the treatment of lung cancer

    BP: Chinese medicine can assist in the treatment of lung cancer

    • Last Update: 2021-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    TCM treatment theory of non-small cell lung cancer: The most basic theory of TCM treatment of non-small cell lung cancer is that when the body's immunity is too weak and the tumor growth capacity is too strong, the imbalance can be adjusted by "strengthening" and "eliminating evil"


    TCM treatment theory of non-small cell lung cancer: "Strengthening the body" means enhancing the body's anti-cancer immunity, while "eliminating evil" directly inhibits the growth, proliferation, invasion and migration of tumor cells


    Comparison of standard treatment of lung cancer and traditional Chinese medicine treatment:

     


    Herbal medicine, acupuncture, moxibustion, diet therapy, physical exercise TCM can regulate the proliferation, apoptosis, adhesion and migration of cancer cells, and inhibit tumor angiogenesis, change the host immune system and inhibit tumor growth


    Adjuvant TCM treatment after surgery: Adjuvant TCM treatment can also prolong the progression-free survival (PFS) of patients with stage II-IIIA NSCLC, reduce mortality, and reduce postoperative tumor recurrence and metastasis


    Adjuvant TCM treatment after chemotherapy/radiotherapy: Combination of Chinese herbal medicine: The 1-year survival rate of TCM maintenance treatment is higher than that of maintenance chemotherapy 2.


    Adjuvant TCM treatment after targeted therapy: The combined adjuvant therapy of TCM and EGFR-TKI has performed well in clinical effects (including PFS, median survival) and safety


    Adjuvant TCM treatment after immunotherapy: Moxibustion with thermal stimulation points Zusanli and Feishu can effectively reduce the ratio of neutrophils to lymphocytes (NLR) in patients with non-small cell lung cancer


    The anti-cancer drugs used in traditional Chinese medicine to "strengthen the body" may open another window for people to discover new immunotherapy





    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.